NO170584C - Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolopyrimidinderivater - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolopyrimidinderivaterInfo
- Publication number
- NO170584C NO170584C NO851654A NO851654A NO170584C NO 170584 C NO170584 C NO 170584C NO 851654 A NO851654 A NO 851654A NO 851654 A NO851654 A NO 851654A NO 170584 C NO170584 C NO 170584C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- analogy procedure
- triazolopyrimidine derivatives
- allergic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/40—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/50—Nitrogen atoms bound to hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59083232A JPS60226887A (ja) | 1984-04-25 | 1984-04-25 | トリアゾロピリミジン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO851654L NO851654L (no) | 1985-10-28 |
| NO170584B NO170584B (no) | 1992-07-27 |
| NO170584C true NO170584C (no) | 1992-11-04 |
Family
ID=13796575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO851654A NO170584C (no) | 1984-04-25 | 1985-04-25 | Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolopyrimidinderivater |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4652646A (xx) |
| EP (1) | EP0159707B1 (xx) |
| JP (1) | JPS60226887A (xx) |
| KR (1) | KR920002133B1 (xx) |
| AT (1) | ATE49765T1 (xx) |
| AU (1) | AU580050B2 (xx) |
| CA (1) | CA1250836A (xx) |
| DE (1) | DE3575562D1 (xx) |
| DK (1) | DK181985A (xx) |
| ES (1) | ES542583A0 (xx) |
| FI (1) | FI81585C (xx) |
| GR (1) | GR850995B (xx) |
| IL (1) | IL75012A (xx) |
| MX (1) | MX8232A (xx) |
| NO (1) | NO170584C (xx) |
| PH (1) | PH21387A (xx) |
| PT (1) | PT80346B (xx) |
| YU (1) | YU44048B (xx) |
| ZA (1) | ZA853113B (xx) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL85207A (en) * | 1987-02-06 | 1992-06-21 | Daiichi Seiyaku Co | 6-substituted thiazolo-(and 1,3,4-thiadiazolo-)(3,2-a)-(1,2,3)triazolo(4,5-d)pyrimidin-9(1h)-ones and their preparation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1338235A (en) * | 1970-12-15 | 1973-11-21 | May & Baker Ltd | Azapurinones |
| US4223031A (en) * | 1978-05-05 | 1980-09-16 | Mead Johnson & Company | Azolopyrimidinones |
| US4366156A (en) * | 1979-03-05 | 1982-12-28 | Mead Johnson & Company | Antiallergic methods using diazaheterocyclopurines |
-
1984
- 1984-04-25 JP JP59083232A patent/JPS60226887A/ja active Granted
-
1985
- 1985-04-19 CA CA000479642A patent/CA1250836A/en not_active Expired
- 1985-04-23 DK DK181985A patent/DK181985A/da not_active Application Discontinuation
- 1985-04-24 EP EP85104988A patent/EP0159707B1/en not_active Expired - Lifetime
- 1985-04-24 YU YU693/85A patent/YU44048B/xx unknown
- 1985-04-24 KR KR1019850002768A patent/KR920002133B1/ko not_active IP Right Cessation
- 1985-04-24 AU AU41640/85A patent/AU580050B2/en not_active Ceased
- 1985-04-24 AT AT85104988T patent/ATE49765T1/de not_active IP Right Cessation
- 1985-04-24 IL IL75012A patent/IL75012A/xx unknown
- 1985-04-24 GR GR850995A patent/GR850995B/el unknown
- 1985-04-24 PT PT80346A patent/PT80346B/pt not_active IP Right Cessation
- 1985-04-24 FI FI851617A patent/FI81585C/fi not_active IP Right Cessation
- 1985-04-24 DE DE8585104988T patent/DE3575562D1/de not_active Expired - Lifetime
- 1985-04-25 ZA ZA853113A patent/ZA853113B/xx unknown
- 1985-04-25 ES ES542583A patent/ES542583A0/es active Granted
- 1985-04-25 PH PH32187A patent/PH21387A/en unknown
- 1985-04-25 US US06/727,044 patent/US4652646A/en not_active Expired - Fee Related
- 1985-04-25 NO NO851654A patent/NO170584C/no unknown
- 1985-04-25 MX MX823285A patent/MX8232A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI81585C (fi) | 1990-11-12 |
| ES8603500A1 (es) | 1985-12-16 |
| KR920002133B1 (ko) | 1992-03-12 |
| JPS60226887A (ja) | 1985-11-12 |
| FI851617L (fi) | 1985-10-26 |
| CA1250836A (en) | 1989-03-07 |
| EP0159707B1 (en) | 1990-01-24 |
| AU580050B2 (en) | 1988-12-22 |
| DK181985A (da) | 1985-10-26 |
| PT80346A (en) | 1985-05-01 |
| DE3575562D1 (de) | 1990-03-01 |
| PT80346B (pt) | 1987-06-17 |
| US4652646A (en) | 1987-03-24 |
| GR850995B (xx) | 1985-11-25 |
| IL75012A (en) | 1988-12-30 |
| KR850007602A (ko) | 1985-12-07 |
| AU4164085A (en) | 1985-10-31 |
| FI81585B (fi) | 1990-07-31 |
| NO170584B (no) | 1992-07-27 |
| JPH0421676B2 (xx) | 1992-04-13 |
| YU44048B (en) | 1990-02-28 |
| FI851617A0 (fi) | 1985-04-24 |
| PH21387A (en) | 1987-10-15 |
| IL75012A0 (en) | 1985-08-30 |
| ATE49765T1 (de) | 1990-02-15 |
| DK181985D0 (da) | 1985-04-23 |
| YU69385A (en) | 1987-10-31 |
| ZA853113B (en) | 1985-12-24 |
| EP0159707A3 (en) | 1986-10-22 |
| NO851654L (no) | 1985-10-28 |
| EP0159707A2 (en) | 1985-10-30 |
| MX8232A (es) | 1993-12-01 |
| ES542583A0 (es) | 1985-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20051265L (no) | Anvendelse av og noen nye imidazopyridiner | |
| NO931921D0 (no) | Fremgangsmaate for fremstilling av nye hydroksamsyre- og n-hydroksyurinstoff-derivater | |
| NO904839L (no) | Fremgangsmaate for fremstilling av benzoxazinderivater. | |
| ES8505379A1 (es) | Un metodo de fabricar 1, 4-dihidropiridina-3-carboxilatos | |
| ES538847A0 (es) | Un derivado de fenilserina | |
| IE38302L (en) | Aromatic hydroxy amines | |
| NO165195C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nye derivater av 4,5-dihydro-oksazolyl-2-((2-pyridyl)-metyl-tio- eller metylsulfinyl)-benz- eller tienoimidazoler. | |
| NO170584C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolopyrimidinderivater | |
| DE2963010D1 (en) | 3-chloro-6-hydroxy-5-methylbenzoic acid derivatives, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds for promoting growth in certain animals and their manufacture | |
| NO891071D0 (no) | Fremgangsmaate for fremstilling av 4,5,6,7-tetrahydro-isotiazolo(4,5-c)-pyridinderivater og isomere. | |
| NO863934D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrido(1,2-a) pyrimidin-derivater. | |
| JPS56120683A (en) | Piperazine derivative of theophylline* its manufacture and therapeutic composition for respiratory disease | |
| NO164170C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzhydryl-4-cinnamyl-piperazinderivater. | |
| NO158676C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-furyl-3,4-dihydroisokinolin-derivater. | |
| NO163133C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktiv 5r, 6s, 8r-6-(1-hydroxyethyl)-2-(2-carbamoyloxy-ethylthio)-penem-3-carboxylsyre. | |
| DE3884878D1 (de) | Uricosuretische Zusammensetzung. |